[Federal Register Volume 60, Number 206 (Wednesday, October 25, 1995)]
[Notices]
[Pages 54696-54697]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-26383]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Cancer Institute; Notice of Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings of the National Cancer Institute Special Emphasis Panel (SEP):

    Name of SEP: Developmental Therapeutics.
    Date: November, 13. 1995.
    Time: 9 a.m.
    Place: 6130 Executive Blvd., Conference Room F, Rockville, MD 
20852.
    Contact Person: Lalita Palekar, Ph.D., Scientific Review 
Administrator, National 

[[Page 54697]]
Cancer Institute, 6130 Executive Blvd., Room 609, Rockville, MD 20852, 
(301) 496-7575.
    Purpose/Agenda: This meeting will be devoted to the review, 
discussion, and evaluation of individual contract proposals.

    Name of SEP: Small Business Innovation Research Program.
    Date: November 15, 1995.
    Time: 1:30 p.m.
    Place: 6130 Executive Blvd., Room 609, Rockville, MD 20852.
    Contact Person: Courtney Michael Kerwin, Ph.D., Scientific 
Review Administrator, National Cancer Institute, 6130 Executive 
Blvd., Room 609, Rockville, MD 20852.
    Purpose/Agenda: Grant Teleconference.

    Name of SEP: Epidemiology.
    Date: November 7, 1995.
    Time: 9 a.m.
    Place: 6130 Executive Blvd., Conference Room J, Rockville, MD 
20852.
    Contact Person: Courtney Michael Kerwin, PH.D., Scientific 
Review Administrator, National Cancer Institute, 6130 Executive 
Blvd., Room 609, Rockville, MD 20852, (301) 496-7421.
    Purpose/Agenda: Review of Contract Proposals.

    The meetings will be closed in accordance with the provisions 
set forth in sec. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395; Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower, 93.399, Cancer Control.)

    Dated: October 18, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-26383 Filed 10-24-95; 8:45 am]
BILLING CODE 4140-01-M